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The recorded reports of cutaneous eruptions due to the antihistaminic drugs have been
few in number (1,2,3,4, 5, 6,7), but none of these has been truly urticarial in nature. McElin
and Horton (1) in 1945 reported one instance of generalized pruritus, following thirty-eight
intravenous injections of Benadryl hydrochloride in twenty-six patients. Epstein (2) re-
ported two patients with atopic eczema who developed eruptions while they were taking
Pyribenzamine. Both eruptions cleared when the drug was discontinued, and recurred
when it was readministered. Harris and Shure (3) reported an eczematoid dermatitis due
to the ingestion of Pyribenzamine by a patient with allergic rhinitis. The eruption recurred
following an additional dose of Pyribenzamine. Rattner and Graffin (4) reported a patient
with a dermatitis medicamentosa due to gold therapy, who developed an exacerbation
after taking Pyribenzamine orally. Sulzberger, Baer and Levin (5) reported two instances
of contact dermatitis which developed following the use of Pyribenzamine ointment in
ninety eases. Another similar case was reported by Strauss (6), whose patient showed a
positive patch reaction to Pyribenzamine ointment and a negative reaction to the ointment
base. Epstein (7) recently reported a patient with a generalized eruption, which appeared
following Trimeton for a dermatitis of the vulval and anal areas. This eruption was at first
urticarial in nature but later developed into a generalized maculo-papular eruption.
In the aforementioned instances of eruptions following the administration of anti-
histaminic drugs, these developed as a result of the treatment of either a preceding atopic
eczema or some other allergic disease. The case described in this report is unique not only
because it presented a true urticaria, but also in that no preceding eruption was present,
nor was there any allergic history in the patient or his family. This patient developed a
typical urticaria following the oral administration of Pyribenzamine.
REPORT OF CASE
H. K., a white medical student, age 23, ingested one 50 mg. tablet of Pyribenzamine for
coryza on October 8, 1948. Forty-five minutes later his face began itching and felt hot and
flushed. Shortly thereafter, an urticarial eruption appeared over his face, associated with
swelling of the eyelids. He was seen by one of us (lvi. M.) within an hour after taking the
tablet, and a diffuse urticarial eruption was noted on the face, chest, abdomen, back and
extremities. A minimal degree of pruritus was noted by the patient. He was given 0.5 cc
of a 1:1000 solution of epinephrine hydrochloride subcutaneously, and the eruption dis-
appeared within an hour.
This patient stated that he had never taken Pyribenzamine or any other similar anti-
histaminic agent prior to the initial dose which produced the eruption. He had never had
any urticaria in the past, nor any other allergic disease.
As a test, on October 15, 1948, he was given one 50 mg. capsule of Benadryl hydrochlo-
ride. No reaction was noted. On October 23, a patch test was performed, using a small
amount of a pulverized tablet of Pyribenzamine moistened with water. No reaction devel-
oped in forty-eight hours. On October 27, 1948, he took orally one 50 mg. tablet of Pyri-
benzamine. As nothing abnormal developed in forty-five minutes, he took another tablet.
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One hour following this, he noticed itching of both cheeks. Fifteen minutes later, on exami-
nation, there were noticed edema of the eyelids, and a diffuse, pruritic, urticarial eruption
on the cheeks, chest, abdomen, back and upper extremities. These were in the form of
wheals, 0.5 to 2 centimeters in diameter. Some coalescence of the wheals on the upper back
was noted. Redness of the shaft of the penis, and a few wheals were present on the buttocks
and thighs, but none on the legs or scrotum. He was given 0.5 cc of a 1:1000 solution of
epinephrine hydrochloride, and again the eruption promptly disappeared.
This patient was tested with an oral dose of the excipient of the Pyribenzamine tablets.'
He developed no eruption following this.
COMMENT
Pyribenzamine and the other antihistaminic agents are commonly used to combat acute
urticarial eruptions, and one of their best known and most efficacious actions has been
noted in this condition. The development of acute urticaria following the oral administra-
tion of Pyribenzamine is difficult to explain, if one accepts the theory that histamine or
histamine-like substances produce urticaria, and that Pyribenzamine couriteracts the
action of histamine. Ratner (8), among others, contends that these drugs have not been
proven to be antihistaminic, either chemically or pharmacologically, and adds that "the
release of histamine has not yet been proved to be the fundamental factor in anaphylaxis
or allergic reactions". Epstein (7) also questions the fact that histamine is really the cause
of the cutaneous manifestations of dermatitis medicamentosa and eczematoid eruptions.
Perhaps future knowledge of the significance of the spreading factor, hyaluronidase, may
shed some light on the mechanism of allergic skin diseases. Mayer and Kull (9) have recently
shown that Pyribenzamine counteracts the spreading effect of India ink and hyaluronidase,
as well as counteracting the latter's effect of increasing the intensity of allergic skin inflam-
mations.
It is interesting that this patient had only mild and transitory itching accompanying a
rather severe urticaria. It has been noted (10) that the symptom of itching is relieved more
consistently and more completely than the edema of urticaria in patients treated with the
antihistaminic drugs. Perhaps this can be explained on the basis of the local anesthetic
action of these drugs.
SUMMARY
Acute urticaria following oral administration of Pyribenzamine is reported in a person
who gave no history of having taken this drug previously, or having had an urticarial erup-
tion. The urticaria promptly disappeared following administration of epinephrine hydro-
chloride. Subsequent administration of Benadryl did not produce the urticaria. A patch
test with Pyribenzamine was negative. Readministration orally of Pyribenzamine pro-
duced a recurrence of urticaria. The eruption did not recur following the oral ingestion of
the excipient used in the tablets of Pyribenzamine. This indicates that the eruption was
due to Pyribensamine alone. No previous report of a similar case has been found by the
authors.
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